ReviewIrish journal of medical science2025
Technology-enhanced compression and AI-integrated lymphedema care: a narrative review.
Review in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-Empowered Mechanomedicine for Cancer-Related Lymphedema.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphedema is a persistent and often debilitating condition resulting from lymphatic system dysfunction. It frequently develops as a secondary complication, especially after cancer treatments. Traditional management, centered on complete decongestive therapy (CDT), offers modest benefits but is limited by accessibility, long-term adherence, and variable patient response.
aimsThis narrative review explores how digital health and enhanced compression technologies are reshaping lymphedema care.
methodsA comprehensive review of pertinent literature was conducted to assess the utilization of artificial intelligence (AI), telehealth platforms, mobile applications, virtual reality-based rehabilitation, and advanced compression devices in the management of lymphedema. Focus was directed towards their clinical efficacy, patient-centered advantages, and the challenges associated with their implementation.
resultsAI-driven instruments exhibit significant promise for precise risk stratification, prompt diagnosis, and individualized treatment planning. Digital platforms-including telehealth services, mobile applications, and virtual rehabilitation programs-improve accessibility, enhance patient engagement, and promote sustained adherence over time. Cutting-edge compression modalities, such as sensor-equipped garments, adaptive pneumatic systems, and vibration-assisted apparatus, deliver dynamic, feedback-informed therapeutic interventions. The amalgamation of these technological advancements with wearable biosensors and AI-powered platforms has yielded promising outcomes in limb volume regulation, rehabilitation efficacy, and overall quality of life. Nevertheless, challenges persist concerning equitable access, compliance with regulatory frameworks, cost-effectiveness, and the preparedness of clinicians.
conclusionDigital health and sophisticated compression methodologies signify a transformative advancement in lymphedema management, promoting anticipatory, individualized, and universally accessible healthcare. Mitigating existing obstacles is crucial for the effective incorporation of these approaches into standard clinical protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.